GALNT14 and hepatocellular carcinoma: This observation implied that a higher level of GALNT14 in pancreatic cancer cells was associated with a poorer clinical outcome, similar to the findings reported in HCC, albeit the correlation between the GALNT14 expression levels and genotypes was opposite in HCC and pancreatic cancer.